186 related articles for article (PubMed ID: 34480729)
41. [A case of advanced hepatocellular carcinoma with inferior vena cava tumor thrombus and multiple intrahepatic metastases treated successfully by transcatheter arterial chemoembolization and radical hepatectomy].
Yamanaka C; Wada H; Hama N; Kobayashi S; Akita H; Kawamoto K; Marubashi S; Eguchi H; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
Gan To Kagaku Ryoho; 2012 Nov; 39(12):1819-21. PubMed ID: 23267897
[TBL] [Abstract][Full Text] [Related]
42. Repeated Perforation of the Gallbladder in a Patient with Hepatocellular Carcinoma Receiving Lenvatinib.
Honda S; Saito Y; Sawada K; Hasebe T; Nakajima S; Okumura T
Intern Med; 2020 Mar; 59(5):657-662. PubMed ID: 31735795
[TBL] [Abstract][Full Text] [Related]
43. Is lenvatinib in combination with transarterial chemoembolization benefit for unresectable hepatocellular carcinoma (uHCC)? The age interference needs to be eliminated.
Li S; Li Y
Hepatol Int; 2024 Apr; 18(2):704-705. PubMed ID: 37943415
[No Abstract] [Full Text] [Related]
44. Interstitial pneumonia suspected during regorafenib administration and exacerbated by subsequent therapy with lenvatinib for unresectable hepatocellular carcinoma.
Kotani K; Enomoto M; Okada M; Yoshida K; Motoyama H; Fujii H; Hagihara A; Uchida-Kobayashi S; Morikawa H; Murakami Y; Tamori A; Kawada N
Clin J Gastroenterol; 2019 Aug; 12(4):355-360. PubMed ID: 31020569
[TBL] [Abstract][Full Text] [Related]
45. Sorafenib Rechallenge and Sorafenib after Lenvatinib Failure in a Patient with Hepatocellular Carcinoma.
Ikeda A; Aoki K; Kawamura M; Yamaguchi D; Kokuryu H
Intern Med; 2021; 60(3):403-407. PubMed ID: 33518611
[TBL] [Abstract][Full Text] [Related]
46. Two hepatectomy cases for initially unresectable hepatocellular carcinoma after achieving a radiological complete response to sequential therapy with lenvatinib and transcatheter arterial chemoembolization.
Endo K; Kuroda H; Abe T; Sato H; Kooka Y; Oikawa T; Sato A; Nishiya M; Sugai T; Takikawa Y
Hepatol Res; 2021 Oct; 51(10):1082-1086. PubMed ID: 33982336
[TBL] [Abstract][Full Text] [Related]
47. Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma.
Hiraoka A; Kumada T; Tada T; Fukunishi S; Atsukawa M; Hirooka M; Tsuji K; Ishikawa T; Takaguchi K; Kariyama K; Itobayashi E; Tajiri K; Shimada N; Shibata H; Ochi H; Kawata K; Toyoda H; Ohama H; Tsutsui A; Itokawa N; Hayama K; Arai T; Imai M; Nakamura S; Michitaka K; Hiasa Y; Kudo M;
Oncology; 2020; 98(5):295-302. PubMed ID: 32097925
[TBL] [Abstract][Full Text] [Related]
48. Power Doppler sonography assessment of tumor recurrence after chemoembolization therapy for hepatocellular carcinoma.
Sumi S; Yamashita Y; Mitsuzaki K; Yamamoto H; Urata J; Nishiharu T; Takahashi M
AJR Am J Roentgenol; 1999 Jan; 172(1):67-71. PubMed ID: 9888742
[TBL] [Abstract][Full Text] [Related]
49. Comparison of hepatectomy and transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma: necessity for prospective randomized trial.
Yoshimi F; Nagao T; Inoue S; Kawano N; Muto T; Gunji T; Ohnishi S; Imawari M
Hepatology; 1992 Sep; 16(3):702-6. PubMed ID: 1324216
[TBL] [Abstract][Full Text] [Related]
50. Isolated cardiac metastases of hepatocellular carcinoma after resection: a case report.
Tamura Y; Kawaoka T; Aikata H; Namba M; Fujii Y; Morio K; Murakami E; Yamauchi M; Hiramatsu A; Nakahara T; Imamura M; Maruhashi T; Kobayashi T; Ohdan H; Kimura T; Nagata Y; Arihiro K; Chayama K
Clin J Gastroenterol; 2020 Jun; 13(3):421-427. PubMed ID: 31782114
[TBL] [Abstract][Full Text] [Related]
51. The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in a real-world setting.
Obi S; Sato T; Sato S; Kanda M; Tokudome Y; Kojima Y; Suzuki Y; Hosoda K; Kawai T; Kondo Y; Isomura Y; Ohyama H; Nakagomi K; Ashizawa H; Miura Y; Amano H; Mochizuki H; Omata M
Hepatol Int; 2019 Mar; 13(2):199-204. PubMed ID: 30671808
[TBL] [Abstract][Full Text] [Related]
52. Rapid intrahepatic tumor seeding after percutaneous ethanol injection therapy for hepatocellular carcinoma.
Tanaka H; Ueda H; Kida Y; Fukuchi H; Ichinose M
Intern Med; 2008; 47(5):411-4. PubMed ID: 18310972
[TBL] [Abstract][Full Text] [Related]
53. FDA Supplemental Approval Summary: Lenvatinib for the Treatment of Unresectable Hepatocellular Carcinoma.
Nair A; Reece K; Donoghue MB; Yuan WV; Rodriguez L; Keegan P; Pazdur R
Oncologist; 2021 Mar; 26(3):e484-e491. PubMed ID: 33044793
[TBL] [Abstract][Full Text] [Related]
54. Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic sonography.
Minami Y; Kudo M; Kawasaki T; Kitano M; Chung H; Maekawa K; Shiozaki H
AJR Am J Roentgenol; 2003 Mar; 180(3):703-8. PubMed ID: 12591679
[TBL] [Abstract][Full Text] [Related]
55. Therapeutic results of computed-tomography-guided transcatheter arterial chemoembolization for local recurrence of hepatocellular carcinoma after initial transcatheter arterial chemoembolization: the results of 85 recurrent tumors in 35 patients.
Tezuka M; Hayashi K; Okada Y; Irie T; Ina H
Dig Dis Sci; 2009 Mar; 54(3):661-9. PubMed ID: 18649138
[TBL] [Abstract][Full Text] [Related]
56. Complete response with sorafenib and transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma.
Takano M; Kokudo T; Miyazaki Y; Kageyama Y; Takahashi A; Amikura K; Sakamoto H
World J Gastroenterol; 2016 Nov; 22(42):9445-9450. PubMed ID: 27895433
[TBL] [Abstract][Full Text] [Related]
57. Criteria for identifying potentially resectable patients with initially oncologically unresectable hepatocellular carcinoma before treatment with lenvatinib plus an anti-PD-1 antibody.
Xu B; Zhu XD; Shen YH; Zhu JJ; Liu J; Li ML; Tang PW; Zhou J; Fan J; Sun HC; Huang C
Front Immunol; 2022; 13():1016736. PubMed ID: 36505445
[TBL] [Abstract][Full Text] [Related]
58. Development of a thrombus in the superior mesenteric artery associated with sequential therapy with tyrosine kinase inhibitors for hepatocellular carcinoma.
Nawa T; Katayama K; Kiyota R; Imai T; Abe Y; Hasegawa N; Takada R; Fukutake N; Ikezawa K; Sakakibara M; Fujita M; Ohkawa K
Clin J Gastroenterol; 2020 Apr; 13(2):247-251. PubMed ID: 31317371
[TBL] [Abstract][Full Text] [Related]
59. Changes in the Mean Intrahepatic Target Computed Tomography Attenuation Value During Treatment May Be a Useful New Predictor of the Post-progression Survival Associated with Lenvatinib Treatment.
Muraishi N; Kawamura Y; Kobayashi M; Shindoh J; Kobayashi Y; Okubo S; Iritani S; Fujiyama S; Hosaka T; Saitoh S; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Ikeda K; Arase Y; Hashimoto M; Yasuda I; Kumada H
Intern Med; 2022 Apr; 61(7):951-958. PubMed ID: 34511564
[TBL] [Abstract][Full Text] [Related]
60. Lenvatinib-Induced Tumor-Related Hemorrhages in Patients with Large Hepatocellular Carcinomas.
Uchida-Kobayashi S; Kageyama K; Yamamoto A; Ikenaga H; Yoshida K; Kotani K; Kimura K; Odagiri N; Hagihara A; Fujii H; Enomoto M; Tamori A; Kubo S; Miki Y; Kawada N
Oncology; 2021; 99(3):186-191. PubMed ID: 33032274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
